ABSTRACT: The predictive factors for long-term dependency (LTD) on noninvasive ventilation (NIV) immediately after acute hypercapnic respiratory failure (AHRF) have not been identified.
N oninvasive ventilation (NIV) is a cornerstone in the management of patients with acute hypercapnic respiratory failure (AHRF) [1, 2] . Several studies have also reported the clear beneficial effects of domiciliary NIV in large series of patients with chronic hypercapnic respiratory failure during the course of restrictive pulmonary diseases [3] [4] [5] . However, the benefits of domiciliary NIV remain controversial in patients with chronic respiratory failure and chronic obstructive pulmonary disease (COPD) [6] [7] [8] [9] [10] [11] [12] [13] .
Long-term domiciliary NIV is usually initiated outside the context of an AHRF episode in patients with chronic respiratory failure, symptomatic nocturnal alveolar hypoventilation, frequent hospitalisations and progressive worsening clinical status and arterial blood gases (ABGs) [8, 9, 14] . However, domiciliary NIV is also initiated in intensive care units (ICUs) after an AHRF episode with impossible or difficult weaning, but criteria to determine who should benefit from long-term domiciliary NIV after this episode have not been clearly established and indications vary between medical teams. Most prospective studies concerning NIV in acute care do not examine this issue, as they focus on the short-term success/ failure of NIV [1, [15] [16] [17] . They do not assess followup after discharge and rarely provide information about the readmission rates for recurrent AHRF or on the incidence of domiciliary ventilatory assistance at discharge [14] .
The aim of the present study was to establish the predictive factors for long-term dependency (LTD)-NIV following the resolution of an AHRF episode in patients managed in a respiratory intermediate care unit (RICU) . Parameters at stable state (during the 6 months prior to the AHRF episode) and at admission into the RICU for the AHRF episode were compared in patients with and without LTD-NIV at discharge. Finally, the present authors compared outcome in patients with and without LTD-NIV during a 1-yr follow-up after discharge from the RICU.
PATIENTS AND METHODS

Patients
During two consecutive years in the RICU of the present authors, all patients admitted for an AHRF episode, who were successfully managed by NIV and subsequently discharged home with or without domiciliary NIV, were retrospectively assessed. AHRF was defined as an exacerbation of dyspnoea lasting for ,1 week associated with respiratory acidosis defined by pH f7.35 and carbon dioxide arterial tension (Pa,CO 2 )o6.6 kPa. Patients who required invasive ventilation during their stay in the RICU were not included in the present study in order to obtain a homogeneous sample of patients successfully treated by NIV alone. All the patients included were required to be free from previous long-term ventilation and were categorised into COPD and non-COPD subgroups according to past medical history and lung function tests. The following patients were excluded from the study: 1) those in whom long-term NIV was considered to be unethical because of the lack of potential benefit; 2) patients in whom long-term NIV was impossible to perform under satisfactory technical conditions; and 3) patients who refused domiciliary NIV.
The weaning process in the RICU of the current authors is standardised as follows. When the patient's condition has stabilised and the triggering factor of AHRF has been controlled, the length of NIV is gradually reduced, during the daytime period only, under close monitoring of clinical respiratory status, and ABG drawn in the early morning and at the end of the day. When daytime NIV is stopped, the possibility of stopping nocturnal NIV is then assessed, on the basis of the patient's clinical condition and ABG values at the end of the following day. Repeat ABGs are performed at any time as required depending on clinical status. Weaning is considered successful when neither clinical alteration nor respiratory acidosis (pH f7.35) is observed within eight consecutive days after completely discontinuing the NIV. If weaning fails, a further attempt is performed using the same procedure. All decisions concerning the initiation of domiciliary long-term NIV were made by three physicians after discussion with the patient, the patient's relatives and nursing staff.
Based on this practice, the present authors define LTD-NIV immediately following AHRF when all of the three following criteria are present: 1) stable resolution of the triggering factor; 2) inability to stop NIV for at least eight consecutive days (after two attempts) because of worsening clinical status, a rise in Pa,CO 2 with respiratory acidosis (pH f7.35) and/or recurrent AHRF without any identifiable cause; and 3) discharge home with domiciliary NIV.
In some cases, long-term NIV is considered as unethical because of the lack of potential benefits, the impossibility to perform long-term NIV under satisfactory technical or safety conditions, or because a patient refuses domiciliary NIV. Patients discharged home with NIV are managed with the technical assistance of a home care network and assessed at outpatient clinics every 3 months.
Management in RICU
The present authors' RICU is a 10-bedded unit with an annual admission rate of ,350 patients, .75% of whom present with AHRF. All of the nurses and respiratory therapists are specifically trained in NIV and a senior respiratory physician dedicated to the unit is on call 24 h. NIV is administrated in the RICU on the basis of standardised protocols. As a first line approach, all patients are ventilated with a face mask and in positive pressure support mode. The initial choice of ventilator is left to the discretion of the duty physician and is influenced primarily by patient tolerability, success/failure of a previous NIV test and the nature of the respiratory impairment at baseline. Inspiratory positive airway pressure is set at a maximal value depending on the patient comfort and ABGs. Expiratory positive pressure is set at a minimal value except in patients with COPD and in those with obstructive sleep apnoea. All patients are ventilated with a back-up frequency rate of 12?min -1 . Inspiratory oxygen fraction is set in order to obtain an arterial oxygen saturation o92%. The inspiratory/expiratory ratio is set depending on the cause of the respiratory impairment (lower in COPD patients and higher in those with restrictive disorders). Changes to the ventilatory settings are decided by the duty physician. After admission with AHRF, patients are ventilated, allowing short periods of spontaneous breathing to permit eating, drinking, performing of bronchial drainage, administering of nebulised bronchodilators and for washing. Clinical state and ABGs are monitored according to an international consensus statement [18] . The intubation criteria are adapted from BROCHARD et al.
[1] requiring one major or two minor criteria to indicate endotracheal intubation. The major criteria include respiratory arrest, gasping, coma, agitation requiring sedation, heart rate ,50 beats?min -1 with unconsciousness and unstable haemodynamic status with systolic arterial pressure ,70 mmHg. The minor criteria include respiratory rate .35 breaths?min -1 and above the rate at admission, arterial oxygen tension ,6 kPa despite oxygen therapy and deterioration of the encephalopathy score.
The cause of the episode of AHRF was established after careful review of each patient's clinical records. The diagnosis of pneumonia was made in the presence of lung infiltrates on chest radiographs, combined with any three of the following factors: fever, positive blood cultures, leukocytosis or potential pathogenic bacterial cultures from sputum, bronchial aspiration or transtracheal aspirates. The current authors defined bronchial infection as the presence of purulent sputum, associated with an increase in baseline dyspnoea and in sputum volume.
Statistical analysis
Continuous variables are presented as mean¡SD, unless otherwise indicated. A univariate analysis was performed in order to determine the individual predictive clinical and functional characteristics for LTD-NIV when collected at steady state and at admission to the RICU for the AHRF episode. In particular, the associations between each discontinuous variable and LTD-NIV were assessed by the Pearson Chi-squared test or Fisher's exact test, as appropriate. The corresponding associations with continuous variables were assessed by the Mann-Whitney U-test. In order to correct for multiple testing, the Bonferroni correction was applied. Specifically, p-values ,0.05/24 or 0.0021 were considered as significant, since 24 tests were performed. Variables that appeared to be independently associated with LTD-NIV at a probability of 10% were used in the multivariate analysis. Forward stepwise logistic regression was used to determine variables that were independently associated with LTD-NIV. Changes in pH and Pa,CO 2 during the stay in the RICU between patients with or without subsequent LTD-NIV were performed using a two-way ANOVA. Day-by-day comparisons were performed using the Mann-Whitney U-test. In patients who stopped NIV within 7 days, the last available value was carried forward (last observation carried forward analysis).
RESULTS
Patient characteristics
A total of 106 patients met the inclusion criteria for the study. Domiciliary NIV on discharge was not considered in six patients who were invalid and bedridden (n52) or who refused home NIV (n54). These six patients were older (mean age 76.3¡9.3 yrs) than the other patients included in the study. Four of these patients had COPD. The median baseline pH in these patients was 7.39 (range 7.34-7.43) and median Pa,CO 2 was 7.0 kPa (range 5-9.8 kPa). A total of four patients (two with COPD and two without COPD) died during the 1-yr follow-up period.
The remaining 100 patients (42 with COPD and 58 without COPD) were included in the analysis. The respiratory conditions present in the non-COPD patients were as follows: chest wall deformities (n521); obesity defined as body mass index (BMI) .30 kg?m -2 (n519); complications of tuberculosis (n510); primary bronchiectasis (n56); neuromuscular disease (n52). The triggering factor for AHRF was identified in 93 patients as the following: bronchial infection (n553); infectious pneumonia (n514); progression of underlying chronic respiratory failure (n513); acute pulmonary oedema (n56); excess sedative use (n53); pneumothorax (n52); pulmonary embolism (n51); and episode of aspiration (n51). No cause was found in seven patients.
LTD-NIV depending on steady state clinical and functional characteristics A total of 31 patients (31%) had LTD-NIV after successful treatment of AHRF. Long-term oxygen therapy had been used previously in 26 patients without LTD-NIV (38%) and in 18 patients with LTD-NIV (58%; p50.058). Fewer of the COPD patients were equipped with home NIV than the non-COPD patients, but the difference was not statistically significant (19% versus 40%; p50.0279). LTD-NIV was not associated with sex, BMI or smoking status (table 1). The incidence of steady state comorbidities, mostly cardiovascular in origin, was similar in patients with or without LTD-NIV.
The proportion of patients hospitalised for AHRF during the previous 3 yrs was similar in non-COPD patients with or without subsequent LTD-NIV (39% versus 40%; p50.95). In contrast, most COPD patients with subsequent LTD-NIV had been admitted to hospital during the previous 3 yrs for AHRF (75% versus 41%; p50.12). There was no significant difference in the number of previous hospital admissions between patients with or without subsequent LTD-NIV with 1.9¡1.6 and 2.6¡2.1 admissions, respectively. These were similar in the COPD and non-COPD patients.
Steady state lung function tests were not predictive for subsequent LTD-NIV either in the whole patient group or in the COPD or non-COPD subgroups (table 2) . LTD-NIV was significantly associated with lower pH and higher Pa,CO 2 values at baseline in the whole patient group and in the non-COPD subgroup (table 3) .
LTD-NIV depending on characteristics of the episode of AHRF
The simplified acute physiology score (SAPS) I severity index on admission was not predictive of LTD-NIV in the entire sample or in either patient group. LTD-NIV was less frequent in patients admitted for AHRF of infectious origin, either bronchial infection or pneumonia ( fig. 1 ). Blood neutrophil count was higher on admission in patients without LTD-NIV (10.8¡7.861000?mm -3 versus 8.6¡7.761000?mm -3 in patients with LTD-NIV), but the difference was not significant (p50.009). There was no difference in the severity of pH on admission to the RICU in patients with or without subsequent LTD-NIV with 7.30¡0.03 versus 7.30¡0.04, respectively (p50.37). Similarly, there was no difference in the severity of fig. 2 ). Measured Pa,CO 2 on spontaneous breathing improved significantly 24 h after admission to the RICU in patients without LTD-NIV (from 9.3¡1.2 to 7.4¡1.2 kPa; p50.0001), but not in patients with LTD-NIV (from 9.6¡1.3 to 9.0¡1.3 kPa; p50.41; fig. 2 ). Similar results were found 48 h after admission.
Daily changes in ABGs measured on mechanical ventilation were different depending on the presence or absence of subsequent LTD-NIV (figs 3 and 4). However, this difference only appeared after the third day of NIV and was only statistically significant in the non-COPD subgroup.
The length of daily NIV was similar during the first 7 days in patients with or without subsequent LTD-NIV. During the first day, mean NIV use was 16.2¡1.4 h in patients without LTD-NIV and 15.8¡1.6 h in patients with LTD-NIV. On the second day, mean NIV use was 12.1¡1.9 h in patients without LTD-NIV and 12.4¡2.3 h in patients with LTD-NIV. Mean daily use fell during the study period until 9.5¡1.9 h (range 7-18) on discharge in patients with LTD-NIV. The length of NIV in RICU in patients with LTD-NIV was 8.3¡6.8 days. The Clinical follow-up after the episode of AHRF All patients were followed up for o1 yr post-discharge. During the follow-up period domiciliary NIV was started in 11 patients because of progressive, deteriorating clinical condition and/or recurrence of AHRF. Treatment, however, was finally stopped in five because of poor tolerance and/or insufficient clinical benefit (table 4). The episode of AHRF on inclusion was the first episode of AHRF in eight of these patients.
No patient had to be tracheostomised during the 1-yr followup. The present authors decided to discontinue domiciliary ventilation in one patient with LTD-NIV in the non-COPD subgroup, because of sustained improvement in clinical parameters and ABGs. However, this patient was hospitalised a further four times for AHRF during the follow-up year and required NIV and endotracheal ventilation.
A total of 50% of the study patients were hospitalised for AHRF at least on one occasion during the 1-yr follow-up period. The proportions of patients with or without LTD-NIV were similar, as was the proportion of patients with or without COPD (table 4) . There was a high requirement for endotracheal intubation in COPD patients with LTD-NIV (60%).
The 1-yr mortality figures were similar in the non-COPD patients whether or not these patients had LTD-NIV, and were similar to the mortality rate in COPD patients without LTD-NIV (table 4) . Most of the deaths in the non-COPD subgroup were in the oldest patients. The mortality rate in COPD patients with LTD-NIV was high, although the number of patients was too small to reach statistical significance.
DISCUSSION
The current study shows that 31% of patients admitted to the authors' RICU with AHRF and without previous home ventilation had LTD-NIV on discharge. Furthermore, the incidence of LTD-NIV is twice as frequent in non-COPD patients (39%) than in COPD patients (19%). These proportions illustrate the significance of ventilatory dependency in post-acute care and are consistent with the recent development of RICUs [19] [20] [21] . RICUs are appropriate structures for assessing this phenomenon because of the extensive NIV use in these units and the higher proportion of patients admitted having chronic respiratory failure and, therefore, more prone to ventilatory dependency.
Few studies have addressed the issue of LTD-NIV after an episode of AHRF and have reported a lower proportion of such patients. This is probably due to differences in the recruitment of patients or in the place where episodes of AHRF are managed: 3-6% of adult patients after admission to ICU have been reported to require prolonged mechanical ventilation [22] [23] [24] , but these data relate mainly to tracheostomised patients managed in the ICU. A recent Italian survey of 26 RICUs [20] , with similar organisation compared with that of the present study, reported 22% of LTD-NIV in a population including post-surgical patients (8%) and/or patients with hypoxaemic respiratory failure (24%). This population included fewer patients with chronic respiratory failure and explains the lower rate of LTD-NIV, compared with patients in the current study. As only limited data are available in the literature, the aim was to identify predictive factors of LTD-NIV in patients discharged from RICU after an episode of AHRF; first, at stable state during the 6 months prior to the episode of AHRF and, secondly, at admission to the RICU. Finally, the outcome in patients with and without LTD-NIV during a 1-yr follow-up after discharge from the RICU was compared.
Among parameters at stable state, the present study demonstrates that the severity of the underlying chronic respiratory failure (attested by a lower pH during a 6-month period before the AHRF episode and not by lung function test parameters) is a strong predictive factor for LTD-NIV on discharge after an episode of AHRF. The occurrence of LTD-NIV also varies depending on the cause of chronic respiratory failure, as a pH value f7.38 at baseline was associated with a 3-fold-higher probability of LTD-NIV on discharge in non-COPD patients compared to patients with COPD. Previous studies showed that the severity of ABG impairment at basal state is an independent predictor of hospitalisation for acute exacerbation in patients with moderate-to-severe COPD [25] and influences long-term mortality after hospital discharge [26] . The presented results add further information to these studies by showing that this parameter is also an independent predictor of LTD-NIV after an AHRF episode in the RICU. However, this information is not always available at admission.
Among parameters collected at admission into the RICU, the authors found that patient severity (based on ABGs and SAPS score) does not predict LTD-NIV on discharge. Furthermore, the rates of pH and Pa,CO 2 improvement on spontaneous breathing are early predictors for LTD-NIV. The current results are different from previous studies which have described predictive factors of immediate NIV success/failure, but have mostly considered patients with COPD and have used intubation and/or mortality as primary endpoints [1, [27] [28] [29] [30] [31] . These studies did not provide any information about LTD-NIV on discharge. The present results suggest that: 1) patient severity at admission cannot be used to assess a possible occurrence of LTD-NIV on discharge; and 2) successful management of an episode of AHRF under NIV, either in COPD or non-COPD patients, does not exclude the potential need for long-term NIV.
Concerning the outcome, the COPD patients with LTD-NIV had a high 1-yr death rate without any fall in their hospitalisation rate. These COPD patients may have been nonresponders to domiciliary NIV, but the fact that 75% of them had been hospitalised at least once for AHRF during the three previous years (with a 50% intubation rate) also suggests that they had advanced COPD disease, less likely to be influenced by domiciliary NIV. The presented results are consistent with published findings showing a poor outcome in COPD patients after successful treatment for AHRF [32] and no benefit in survival when long-term NIV is started in COPD [11, 12, 33] . Future studies are needed to address the impact of long-term NIV on other important outcomes, such as hospitalisation rates [14] and health status; this latter parameter was not assessed in the current study because of its retrospective design. This study, therefore, suggests that LTD-NIV after an episode of AHRF is a marker of disease severity during COPD. This does not apply to non-COPD patients, probably because these patients are suffering from a range of different pulmonary disorders.
The main limitations of this study stem from its retrospective design and the fact that the present authors used a procedure to stop NIV that has not been validated previously. To the best of the present authors' knowledge, there are no guidelines or prospectively standardised procedures to perform weaning from NIV, as compared with published weaning protocols for invasive ventilation. Although the patients in this study were managed using standardised procedures throughout the study period, by an experienced medical and nursing team, the consistent practice in the RICU does not replace a prospectively validated weaning protocol and a prospectively validated definition of LTD-NIV.
In conclusion, the current study shows that long-term dependency on noninvasive ventilation after acute hypercapnic respiratory failure is a common situation in respiratory intermediate care units, especially in patients with non-COPD causes of respiratory failure. Prediction of long-term 
